Cargando…

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis

Tumor metastasis remains the main cause of breast cancer-related deaths, especially delayed breast cancer distant metastasis. The current study assessed the frequency of CD44(-)/CD24(-) breast cancer cells in 576 tissue specimens for associations with clinicopathological features and metastasis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Xinbo, Zhang, Yixiao, Sun, Lisha, Ma, Qingtian, Yang, Jie, Ai, Liping, Xue, Jinqi, Chen, Guanglei, Zhang, Hao, Ji, Ce, Gu, Xi, Lei, Haixin, Yang, Yongliang, Liu, Caigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346282/ https://www.ncbi.nlm.nih.gov/pubmed/34318746 http://dx.doi.org/10.7554/eLife.65418

Ejemplares similares

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2022)

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
por: Qiao, Xinbo, et al.
Publicado: (2023)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2(+)HR(+) breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells
por: Pal, Debjani, et al.
Publicado: (2017)

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
por: Sun, Lisha, et al.
Publicado: (2022)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
por: Xing, Fei, et al.
Publicado: (2023)

CEMIP as a potential biomarker and therapeutic target for breast cancer patients
por: Xue, Jinqi, et al.
Publicado: (2022)

CD44 increases the efficiency of distant metastasis of breast cancer
por: McFarlane, Suzanne, et al.
Publicado: (2015)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity
por: Ramos, Erika K, et al.
Publicado: (2022)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer
por: Zhu, Xudong, et al.
Publicado: (2019)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
por: Asai, Ryoma, et al.
Publicado: (2019)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma
por: Zhang, Yixiao, et al.
Publicado: (2021)

CD44‐associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage
por: Liu, Wei‐Hsiu, et al.
Publicado: (2019)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
por: Kamarajan, Pachiyappan, et al.
Publicado: (2013)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

CD44v9 is associated with epithelial‐mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma
por: Taniguchi, Daisuke, et al.
Publicado: (2018)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)

SALL4 ‐ KHDRBS3 network enhances stemness by modulating CD44 splicing in basal‐like breast cancer
por: Matsumoto, Yoshiaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qg51ki4bsshdjv8nv7m3m9lfid